We are proud to announce that ACARE has partnered with ITACA, the Italian Network for Hereditary and Acquired Angioedema. ACARE and ITACA share common interests, and members of both networks are expert centers for all forms of angioedema and can diagnose, certify and treat HAE as well as angioedema due to acquired C1INH-deficency, contact system activation and mast cell degranulation.
ACARE and ITACA centers employ a multidisciplinary approach and are able to address any clinical needs in pediatric and adult populations. From now on, ITACA will guide their member centers in becoming ACAREs and audits will be conducted jointly (with final approval by the ACARE Steering Committee).
We are looking forward to this undoubtedly fruitful collaboration and to gaining many new ACARE centers in Italy.
Read more news from ACARE
Reminder March 29, 2:30 – 7:00 pm CEST: STATE OF THE ART MANAGEMENT OF RECURRENT ANGIOEDEMA AND HANDS ON TRAINING with special focus on Canada and EuropeMarch 28, 2023
STATE OF THE ART MANAGEMENT OF RECURRENT ANGIOEDEMA AND HANDS ON TRAINING with special focus on Canada and Europe (applied for CME) Click here to register. The overall aim [...]
Dr. Karsten Weller speaks on using the patient’s perspectives to guide HAE management. Episode 2 of the HAE Relay: Expert Exchange video seriesMarch 2, 2023
The HAE Relay: Expert Exchange video series is designed to provide engaging and informative bite-size content to healthcare professionals who are either new to hereditary angioedema (HAE), or are established [...]
- February 21, 2022
If you want to improve the collaboration with your patients to better control their HAE, we recommend that you advise your patients to use the new HAE TrackR app. Developed [...]